Clinical Trial Technology Editorial

31. AI In Drug Discovery And Development — Will It Live Up To The Hype? 1/5/2024

    While AI may soon transform the drug discovery and development process, there are still several barriers, both technical and ethical, to the rise of AI in biopharma.

32. ClinOps Digital Transformation: Tips For Getting It Right The First Time 1/5/2024

    Despite the digital “revolution” being more than 70 years old, digital transformation continues and mistakes are still being made. But that does not need to be the case.

33. What Clinical Trial Experts Think Will Happen With AI In 2024 12/26/2023

    In part one of this preview of clinical trials trends for 2024, experts discuss the applications of AI in clinical research.

34. An Overview Of Patient Service Programs Technology 12/15/2023

    Discover all the applicable technologies aimed at improving patient adherence, patient access, patient affordability, and patient advocacy.

35. My Opinion: CRCs, CRAs, and CTMs Have It Tough 11/27/2023

    With 20+ years as a CRC, CRA, clinical trial manager, and project manager, Tiffany Ashton, MAS, CCRA talks about how difficult it can be working in some of these roles in today’s clinical trials industry. 

36. Putting Patients First: Human-Centric Approaches In Digital Healthcare 11/8/2023

    Human-centric design should be the starting point for identifying the core issues that drive innovation, experimentation, and finding solutions to unlock the full potential of digital health. Amy West, head of U.S. digital transformation & innovation at Novo Nordisk, explains.

37. Automating Quality Assurance In Neurology Trials Using Speech Analytics 11/1/2023

    By automating quality assurance (QA) in clinical trials with speech analysis, sponsors can improve trial data and avoid the high cost and variable dependability of using specialized raters.

38. Legal And IP Protection For New Biotechs 10/31/2023

    Want to ensure you've got your biotech legal, IP, and patent bases covered? Join Business of Biotech host Matt Pillar and BlueSphere Bio CEO and biotech legal expert Keir LoIacono on 11/13 for the live, interactive, and FREE digital event Legal And IP Protection For New Biotechs. 

39. An Overview Of FDA Efforts To Encourage DHT Use In Drug & Biological Product Development 10/30/2023

    The FDA issued its Framework for the Use of Digital Health Technologies in Drug and Biological Product Development earlier this year, representing the agency's road map on the topic. Digital health technologies (DHTs) may include wearable, implantable, or software applications, among other approaches. This article takes a closer look at the framework as well as related FDA efforts this year.

40. As Protocol Complexity Grows, AI Decreases Site Workload And Improves Patient Recruitment 10/23/2023

    Cedar Health Research CEO Todd Albin discusses ways in which AI-assisted technologies can improve upon traditional patient recruitment and enrollment strategies.